Pemphigus vulgaris—a blistering clinical enigma: case report Authors: Anuradha Ganesan, Vinu B Priya, Krithika Chandrasekar Lakshmi, Yesoda Aniyan Published: 2026 ABSTRACT BackgroundUpper aerodigestive tract involvement in pemphigus requires early multidisciplinary evaluation because there can be involvement in the oral cavity, pharynx, larynx and glottis and thus to upper airway as well. Pemphigus vulgaris (PV) is an autoimmune blistering disorder characterized by painful mucocutaneous vesicles and bullae that rupture to form severe erosions. The disease results in intraepithelial blister formation due to immunoglobulin G autoantibodies targeting desmoglein-3(DSG3), and sometimes desmoglein 1(DSG1). Oral lesions are the most common manifestation and serve as the initial sign in 80–90% of cases. Early diagnosis and management of oral involvement are essential to prevent skin lesions and improve the likelihood of achieving early remission. Corticosteroids remain the cornerstone of therapy.Case presentationA 35-year-old South Asian male of Indian origin, belonging to the Dravidian ethnic group, presented with a one-month history of multiple ulcers in the oral cavity marked by intermittent exacerbations and remissions. Extra-oral examination revealed multiple blisters in chest and back of the body. Intra-oral examination revealed multiple oral ulcers and an exfoliative cytology revealed scattered exfoliated epithelial cells and clumps of rounded acantholytic cells resembling Tzanck cells. Oral incisional biopsy was done for histopathological and immunological investigations and a definitive diagnosis of Pemphigus Vulgaris was made .ConclusionThis case highlights the importance of thorough clinical evaluation, careful histopathological and immunofluorescence studies to distinguish PV from a broad range of mucocutaneous blistering disorders. Despite limitations in therapeutic availability, appropriate use of systemic corticosteroids, supportive care, and consideration of steroid-sparing agents are critical components of treatment. Multidisciplinary collaboration is essential, especially in cases with upper aerodigestive tract involvement.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12903-026-08909-z. Introduction Pemphigus, a rare autoimmune disease affecting the skin and mucous membranes, with its name derived from the Greek word “pemphix,” meaning blister [1]. Its global incidence ranges from 0.5 to 3.2 per million annually, with lower prevalence in India (0.09–1.8%) [2]. Recent systematic review and epidemiological studies report a global incidence that varies geographically approximately (0.1–5 per 1,00,000) and confirms pemphigus vulgaris is the most common subtype. Due to the regional variability, there is a need to estimate the disease burden worldwide. With its strong genetic and environmental predisposition, this disease is often manifested among individuals of Ashkenazi Jewish, Japanese, and Mediterranean descent. The predilection, in gender slants towards women and age, in the fifth to sixth decades of life. However, currently it is being reported in younger populations, including childhood (≤ 12 years) and juvenile/adolescent (12–18 years) [3]. Pemphigus includes several subtypes like pemphigus vulgaris, pemphigus vegetans, pemphigus foliaceus, pemphigus erythematosus, paraneoplastic pemphigus (PNP) and drug related pemphigus with pemphigus vulgaris (PV) being the most common, accounting for over 80% of cases and frequently involving oral lesions [4]. The etiopathogenesis identifies PV as an autoimmune disorder characterized by IgG autoantibodies against desmosomal proteins (desmogleins), causing disruption of intraepidermal cell to cell adhesion (acantholysis) and resulting in the formation of vesicles, bullae, and erosions. The IgG autoantibodies are primarily, desmoglein 3 and desmoglein 1. The pathogenesis involves multiple mechanisms including steric hindrance of desmosomal adhesion, activation of intracellular signaling pathways, and induction of keratinocyte apoptosis. Additionally, genetic susceptibility, drugs, infections, and psychological stress are implicated in the initiation and exacerbation of the disease [5].These lesions usually precede skin symptoms and commonly affect the buccal mucosa, followed by palatal, lingual and labial areas with desquamative gingivitis as the typical gingival manifestation [6]. Diagnostic confirmation requires clinicopathological correlation along with lesional histology and immunofluorescence supplemented with serum testing. Early diagnosis and management are crucial to prevent disease progression [7]. The management of pemphigus vulgaris primarily involves systemic corticosteroids as first-line therapy and combinations with steroid-sparing immunosuppressive agents such as azathioprine, mycophenolate mofetil, or rituximab. The combination enhances therapeutic efficacy and reduces long-term corticosteroid-related adverse effects. This case report is clinically significant for its rare involvement of the upper aerodigestive tract, including the pharynx, larynx and oesophagus, which poses potential airway compromise and mandates early recognition and a multidisciplinary management. Case report Clinical description A 35-year-old South Asian male of Indian origin, belonging to the Dravidian ethnic group, presented with the chief complaint of multiple ulcers in the oral cavity for past one month. The history of presenting illness detailed an episode of ulcer preceded by blisters formation and rupture along the borders of the tongue and lower lip. Patient also complaints of bleeding from the nose and swelling in the left side along the submandibular region with difficulty of swallowing. The patient self-administered homeopathic medication, which provided temporary symptomatic relief, however the ulcers persisted. The patient stated that he had no major medical problems in the past and had been getting orthodontic treatment for the past year. There was also no relevant family history. Extra-oral examination revealed multiple blisters on the chest and back of the body. Intra-oral examination revealed multiple ulcers in right lower labial vestibule, posterior buccal mucosa, retromolar region, junction of soft and hard palate extending to pharynx which were 1.5 × 1 cm ,0.5 × 0.5 cm ,0.5 × 0.5 cm ,0.1 × 0.1 cm respectively. Extending anteroposteriorly from 1 cm away from angle of the mouth upto retromolar region and extending to the tonsillar region and posterior pharynx and superoinferiorly 2 cm away from both upper and lower buccal vestibule. The ulcers were irregular in shape and of variable sizes. The margins were irregular and the surrounding mucosa appeared to be erythematous as seen in Fig. 1. On palpation, the ulcers were tender, with no discharge/bleeding on pressure. Lymph node examination revealed presence of single solitary lymph node present bilaterally on both left and right submandibular region which were 1 × 1 cm in size, tender, freely movable, and not attached to underlying structure. Based on the clinical presentation, a provisional diagnosis of pemphigus vulgaris was considered, with differential diagnoses including mucous membrane pemphigoid, erosive oral lichen planus, bullous lichen planus, and erythema multiforme. This case report has been prepared in accordance with the CARE (CAse REport) guidelines, which provide a standardized framework to enhance the accuracy, transparency, and completeness of clinical case reporting. Fig. 1Multiple ulcers and blisters involving various mucocutaneous sites. A Tongue showing irregular ulcerations. B Buccal mucosa extending to the retromolar region with diffuse erosions. C Chest region showing cutaneous vesiculobullous lesions and crusted erosions. D Lower lip with ulceration and hemorrhagic crusting. E Junction of hard and soft palate exhibiting erosive lesions Multiple ulcers and blisters involving various mucocutaneous sites. A Tongue showing irregular ulcerations. B Buccal mucosa extending to the retromolar region with diffuse erosions. C Chest region showing cutaneous vesiculobullous lesions and crusted erosions. D Lower lip with ulceration and hemorrhagic crusting. E Junction of hard and soft palate exhibiting erosive lesions Diagnostic assessment Routine blood investigations, including complete blood count and liver function tests were within normal limits, helping to exclude systemic causes. Radiological evaluation with CT scan of the neck revealed sub-centimetric bilateral level II, III, and IV cervical lymph nodes, the largest measuring 4 mm in short-axis diameter, suggestive of reactive lymphadenopathy. Ultrasound examination of the abdomen was unremarkable. Based on the clinical presentation of multifocal mucosal ulcerations involving the soft palate, hard palate, posterior pharyngeal wall, epiglottis, and cricopharynx (Fig. 2), a provisional diagnosis of an autoimmune vesiculobullous disorder was considered, with differential diagnoses including pemphigus vulgaris, mucous membrane pemphigoid, and erosive lichen planus. Initial cytological assessment using exfoliative cytology revealed scattered epithelial cells and clumps of rounded acantholytic (Tzanck) cells, along with inflammatory infiltrate, supporting a diagnosis of an intraepithelial blistering disorder. Histopathological examination of an oral incisional biopsy demonstrated suprabasal clefting with acantholysis and intraepidermal abscess formation, further narrowing the diagnosis toward pemphigus vulgaris. Immunopathological confirmation was obtained through direct immunofluorescence (DIF) of perilesional tissue, which showed intercellular deposition of IgG and C3 in a characteristic “fishnet” pattern(Fig. 3). Indirect immunofluorescence (IIF) detected circulating autoantibodies in the patient’s serum, correlating with disease activity. Enzyme-linked immunosorbent assay (ELISA) demonstrated autoantibodies against desmoglein 1 and desmoglein 3, confirming the target antigens associated with pemphigus vulgaris. Additionally, skin biopsy from the chest region showed intercellular IgM deposition. Based on the integration of clinical, cytological, histopathological, and immunological findings, a definitive diagnosis of pemphigus vulgaris was established. Disease severity was assessed using clinical parameters and validated indices. Nikolsky’s sign was recorded at baseline and follow-up, and disease activity was quantified using the Pemphigus Disease Area Index (PDAI), with a baseline mean score of 20.2 ± 8.4. Fig. 2Histopathological and endoscopic findings at baseline and follow-up. A–C Histopathological photomicrographs showing characteristic features of pemphigus vulgaris, including suprabasal clefting, intraepidermal abscess formation, and prominent acantholysis of keratinocytes. D–F Endoscopic images of the larynx and pharynx at initial presentation demonstrating extensive mucosal ulceration, erythema, and erosive lesions indicating active disease involvement. G–I Follow-up endoscopic images at 3 months showing significant clinical improvement with resolution of ulcerations, reduced erythema, and mucosal healing Fig. 3Cytological and immunopathological findings. A Exfoliative cytology smear showing scattered epithelial cells and clusters of rounded acantholytic (Tzanck) cells. B Direct immunofluorescence of perilesional tissue demonstrating intercellular deposition of IgG in a characteristic “fishnet” pattern along keratinocyte surfaces Histopathological and endoscopic findings at baseline and follow-up. A–C Histopathological photomicrographs showing characteristic features of pemphigus vulgaris, including suprabasal clefting, intraepidermal abscess formation, and prominent acantholysis of keratinocytes. D–F Endoscopic images of the larynx and pharynx at initial presentation demonstrating extensive mucosal ulceration, erythema, and erosive lesions indicating active disease involvement. G–I Follow-up endoscopic images at 3 months showing significant clinical improvement with resolution of ulcerations, reduced erythema, and mucosal healing Cytological and immunopathological findings. A Exfoliative cytology smear showing scattered epithelial cells and clusters of rounded acantholytic (Tzanck) cells. B Direct immunofluorescence of perilesional tissue demonstrating intercellular deposition of IgG in a characteristic “fishnet” pattern along keratinocyte surfaces Diagnosis and therapeutic interventions The patient was referred to a general physician and dermatologist due to extensive involvement of the pharynx, larynx, and oesophagus. The treatment protocol was formulated in accordance with established international consensus guidelines for pemphigus, which recommend systemic corticosteroids as the first-line therapy for moderate to severe disease, supplemented with topical and supportive care .Accordingly, the patient was initiated on oral methylprednisolone at a dose of 0.5–1 mg/kg/day (48 mg/day), consistent with European and International guidelines for the management of pemphigus vulgaris [8]. Clinical response and potential adverse effects were closely monitored on a weekly basis, including blood pressure, fasting blood glucose, complete blood count, and liver and renal function tests as recommended in standard corticosteroid monitoring protocols .Supportive therapy was instituted in line with adjunctive care recommendations. The patient received Vitamin D3 (60,000 IU weekly), paracetamol 650 mg twice daily and a multivitamin multimineral supplement to address nutritional status and corticosteroid-related deficiencies. Topical management included sodium fusidate 2% cream, triamcinolone acetonide 0.1% oral paste, and a combination oral gel containing chlorhexidine gluconate, lidocaine hydrochloride and metronidazole, applied three times daily after meals to reduce secondary infection, inflammation, and discomfort [9] .For gastric protection, a combination of domperidone and rabeprazole (30 mg + 20 mg) was prescribed twice daily before meals, in accordance with recommendations to prevent corticosteroid-induced gastrointestinal complications. The overall treatment approach aligns with evidence-based protocols emphasizing early systemic therapy, multidisciplinary care and comprehensive supportive management in pemphigus vulgaris. Follow-up and outcome of interventions First follow up after two months, patient came for review with mild reduction in ulceration and no new ulcer formation. At 12-week follow-up the PDAI reduced to 10.3 ± 3.7 reflecting nearly 50% improvement in disease severity. Additionally, the positive nikolsky sign was also not present and was negative during follow-up. With significant reduction in the lesions (Fig. 4), the dose of methylprednisolone was tapered gradually with careful monitoring of relapse. Following marked clinical improvement, the dose of methylprednisolone was tapered in a structured stepwise manner from 48 mg/day to 40 mg/day for 2 weeks, then to 32 mg/day for 2 weeks, followed by 24 mg/day for 2 weeks, 16 mg/day for 2 weeks, 8 mg/day for 2 weeks, and finally discontinued after completion of therapy. The patient was reviewed regularly throughout the tapering period and no evidence of relapse was observed. To achieve steroid sparing effect cyclophosphamide was added as an adjunct immunosuppressant and was given as 50 mg/day orally to the patient. Cyclophosphamide is normally indicated in the management of severe refractory/rapidly progressing disease. A close laboratory monitoring was done in our patient including complete blood count, renal and liver function test. Patient was also counselled regarding fertility preservation strategies prior to initiation of cyclophosphamide as it carries significant risk of gonodotoxicity furthermore due to immunosuppression the patient was also advised for infection control measures, timely vaccinations and prophylactic antimicrobial if required. The patient was asked to continue with the supportive treatment regimen and topically was prescribed Azelaic acid cream 15 gm, Benzoyl peroxide 2.5%gel, to be applied over the affected area for three times a day. For gastric protection Esomeprazole and Domperidone 20 mg capsules were prescribed twice daily instead of Rabeprazole. (Table 1) Fig. 4Post-treatment clinical images at 3-month follow-up showing significant regression of lesions, with near-complete resolution of ulcerations, decreased inflammation, and evidence of mucosal healing Post-treatment clinical images at 3-month follow-up showing significant regression of lesions, with near-complete resolution of ulcerations, decreased inflammation, and evidence of mucosal healing Table 1Timeline of events➢ Patient complains of multiple oral ulceration for 1 month after initiation of orthodontic treatment.➢ Mild relief of symptoms with homeopathy medication with persistent oral ulceration➢ Intra-oral - Pain and ulcer in right lower labial vestibule, posterior buccal mucosa, retromolar region, junction of soft and hard palate extending to pharynx.➢ Extra-oral -Multiple blisters in chest & dorsal surface of the body.➢ DiagnosisClinical and histopathological examination, Skin Immunofluorescence, Endoscopy of pharynx, larynx & CT neck.➢ Treatment ✓ Methyl prednisolone tablet 48 mg/day (0.5-2 mg/kg) twice daily orally, ✓ Vitamin D3 60,000 IU s/f 5 ml once a week as an oral dose after dinner ✓ Paracetamol 650 mg twice daily after meal orally, ✓ Sodium fusidate 2%W/W 10gm cream, ✓ Triamcinolone acetonide 0.1%(5gm) oral paste to be applied thrice daily, ✓ Chlorhexidine gluconate and lignocaine Hydrochloride and metronidazole 20gm oral gel to be applied thrice daily, ✓ Multivitamin and Multimineral 200 ml syrup 10 ml/day every morning, ✓ Domperidone and rabeprazole (30 mg+20 mg) capsule twice daily before meal.➢ Follow-upAfter 2 months: Reduction of ulcerations with ✓ Steroid tapering with Methyl prednisolone 32 mg/day tab twice daily orally, ✓ Azelaic acid skin cream 15 gm for 1 week & Benzoyl peroxide 2.5%gel to be applied thrice daily, ✓ Esomeprazole and Domperidone 20 mg capsule were prescribed twice daily before meal, ✓ Immunomodulator: Cyclophosphamide 50 mg/day once at afternoon after meal orally.After 3 months (12 weeks):Significant reduction of ulcerations was noticed and the patient is still under follow-up with steroid maintenance dose of 8 mg /day with no occurrence of new lesions and complete resolution of the disease. Table 1Timeline of events➢ Patient complains of multiple oral ulceration for 1 month after initiation of orthodontic treatment.➢ Mild relief of symptoms with homeopathy medication with persistent oral ulceration➢ Intra-oral - Pain and ulcer in right lower labial vestibule, posterior buccal mucosa, retromolar region, junction of soft and hard palate extending to pharynx.➢ Extra-oral -Multiple blisters in chest & dorsal surface of the body.➢ DiagnosisClinical and histopathological examination, Skin Immunofluorescence, Endoscopy of pharynx, larynx & CT neck.➢ Treatment ✓ Methyl prednisolone tablet 48 mg/day (0.5-2 mg/kg) twice daily orally, ✓ Vitamin D3 60,000 IU s/f 5 ml once a week as an oral dose after dinner ✓ Paracetamol 650 mg twice daily after meal orally, ✓ Sodium fusidate 2%W/W 10gm cream, ✓ Triamcinolone acetonide 0.1%(5gm) oral paste to be applied thrice daily, ✓ Chlorhexidine gluconate and lignocaine Hydrochloride and metronidazole 20gm oral gel to be applied thrice daily, ✓ Multivitamin and Multimineral 200 ml syrup 10 ml/day every morning, ✓ Domperidone and rabeprazole (30 mg+20 mg) capsule twice daily before meal.➢ Follow-upAfter 2 months: Reduction of ulcerations with ✓ Steroid tapering with Methyl prednisolone 32 mg/day tab twice daily orally, ✓ Azelaic acid skin cream 15 gm for 1 week & Benzoyl peroxide 2.5%gel to be applied thrice daily, ✓ Esomeprazole and Domperidone 20 mg capsule were prescribed twice daily before meal, ✓ Immunomodulator: Cyclophosphamide 50 mg/day once at afternoon after meal orally.After 3 months (12 weeks):Significant reduction of ulcerations was noticed and the patient is still under follow-up with steroid maintenance dose of 8 mg /day with no occurrence of new lesions and complete resolution of the disease. Timeline of events ➢ Intra-oral - Pain and ulcer in right lower labial vestibule, posterior buccal mucosa, retromolar region, junction of soft and hard palate extending to pharynx. ➢ Extra-oral -Multiple blisters in chest & dorsal surface of the body. ➢ Diagnosis Clinical and histopathological examination, Skin Immunofluorescence, Endoscopy of pharynx, larynx & CT neck. ➢ Treatment ✓ Methyl prednisolone tablet 48 mg/day (0.5-2 mg/kg) twice daily orally, ✓ Vitamin D3 60,000 IU s/f 5 ml once a week as an oral dose after dinner ✓ Paracetamol 650 mg twice daily after meal orally, ✓ Sodium fusidate 2%W/W 10gm cream, ✓ Triamcinolone acetonide 0.1%(5gm) oral paste to be applied thrice daily, ✓ Chlorhexidine gluconate and lignocaine Hydrochloride and metronidazole 20gm oral gel to be applied thrice daily, ✓ Multivitamin and Multimineral 200 ml syrup 10 ml/day every morning, ✓ Domperidone and rabeprazole (30 mg+20 mg) capsule twice daily before meal. ➢ Follow-up After 2 months: Reduction of ulcerations with ✓ Steroid tapering with Methyl prednisolone 32 mg/day tab twice daily orally, ✓ Azelaic acid skin cream 15 gm for 1 week & Benzoyl peroxide 2.5%gel to be applied thrice daily, ✓ Esomeprazole and Domperidone 20 mg capsule were prescribed twice daily before meal, ✓ Immunomodulator: Cyclophosphamide 50 mg/day once at afternoon after meal orally. After 3 months (12 weeks):Significant reduction of ulcerations was noticed and the patient is still under follow-up with steroid maintenance dose of 8 mg /day with no occurrence of new lesions and complete resolution of the disease. Discussion Pemphigus Vulgaris (PV) is a life-threatening mucocutaneous disorder primarily caused by autoantibodies binding to the epithelial cell membrane, leading to the formation of intraepithelial blisters filled with acantholytic cells. PV can be triggered by genetic predisposition, foods, infections, neoplasms, or drugs, with thiol-containing drugs like Angiotensin converting enzyme inhibitors, penicillamine, non-steroidal anti-inflammatory drugs and certain antibiotics being frequently implicated [10]. A detailed review of the patient’s pharmacological history should therefore be undertaken with specific attention to initiation of new agents preceding disease onset or exacerbation. In our present case the treatment history was scrutinized carefully and no recently introduced drugs were identified making a drug induced etiology unlikely. The present case highlights an uncommon yet clinically significant presentation of pemphigus vulgaris with extensive aerodigestive tract involvement, including the pharynx, larynx, and proximal oesophagus. While oral mucosal lesions are well recognized as the initial manifestation in most cases, deeper aerodigestive involvement is relatively rare and often underreported, leading to potential delays in diagnosis [11]. Similar cases described in the literature have reported laryngeal and oesophageal extension presenting with dysphagia, odynophagia and airway-related symptoms; however, the extent and distribution of lesions in the current case appear more widespread, underscoring the need for thorough endoscopic evaluation in patients with persistent or atypical mucosal ulcerations [12]. A hallmark feature of PV is Nikolsky’s sign, where pressure on affected skin causes blistering or sloughing. The oral mucosa is often affected before skin lesions, with common symptoms including blisters, erosions and ulcers, particularly in areas like the buccal mucosa, soft and hard palate and gingiva [7]. When evaluating a patient with mucocutaneous blistering and erosive lesion a broad differential diagnosis must be considered. Mucous membrane pemphigoid (MMP) and Bullous pemphigoid (BP) often presents with subepithelial blisters and mucosal involvement however histopathology typically reveals a subepithelial cleft rather than suprabasal acantholysis which is characteristics of pemphigus. DIF in MMP and BP shows linear deposition of IgG and C3 along the basement membrane zone in contrast to intercellular fish net pattern seen in pemphigus. Paraneoplastic pemphigus (PNP) may also be considered particularly in the presence of severe stomatitis and extensive skin lesions. Histology may demonstrate acantholysis with lichenoid changes and DIF reveals both cell surface and basement membrane staining. Erythema multiforme (EM) and Steven Johnson Syndrome (SJS) can mimic pemphigus with wide spread erosions but are acute and self-limiting and associated with infections or drugs. Histology shows subepidermal clefting rather than acantholysis. Erosive Lichen Planus presents with painful erosion and reticular striae and demonstrates and band of lymphocytic infiltration and basal cell degeneration on histology. DIF of erosive lichen planus reveals shaggy fibrin and fibrinogen deposition along the basement membrane. Herpes simplex virus infection may also produce extensive ulcerative lesion but is distinguished by multinucleated giant cells on tzanck smear, viral cytopathic changes and negative DIF. In the present case the combination of suprabasilar acantholysis in histopathology and intercellular IgG and C3 deposition in a fish net pattern on DIF effectively excludes these alternatives and thereby confirms the diagnosis of pemphigus vulgaris. Treatment for PV typically involves systemic corticosteroids like prednisolone, starting at 0.75–1 mg/kg per day, with possible escalation if needed. Adjuvant immunosuppressants may be used to minimize steroid use. In recent years several steroids sparing and targeted therapeutic options have emerged in the management of pemphigus most notably Rituximab, monoclonal antibody against CD20 positive B cells. It shows superior efficacy compared to conventional steroid regimens leading to fewer long term adverse effects and high rates of sustained remission. In a clinical trial Rituximab was given to patients who did not respond to conventional therapy or patient who had relapse. The results showed complete remission in all patients and was well tolerated with no serious adverse events and was a safe and effective treatment option for pemphigus [13]. Additional therapies such as Intravenous immunoglobulins, mycophenolate mofetil and azathioprine can also be used as alternative when Rituximab is contraindicated [14]. In this case steroids sparing therapy was considered however rituximab was not used due to high cost and limited availability in the treatment settings. Upper aerodigestive tract involvement in pemphigus requires early multidisciplinary evaluation because there can be involvement in the oral cavity pharynx, larynx and glottis leading to upper airway involvement in secondary infection [15]. Management therefore combines immunotherapy with supportive care. Therapeutic algorithm of such cases increasingly uses Rituximab early in the treatment for higher rates of sustained remission and steroids sparing benefits compared to prolonged corticosteroid therapy. To minimize the treatment related adverse effects proton pump inhibitors are administered in patients’ high dose or prolonged systemic corticosteroids to reduce gastritis, peptic ulcers and gastrointestinal bleeding [16]. They are generally prescribed throughout the duration of high dose steroid therapy and can be tapered or discontinued once the corticosteroid dose is reduced [17].Topical medications were also prescribed to alleviate pain promote healing and reduce the risk of secondary infection [18]. However, all such supportive measures should be tailor made and continued as long as systemic immunosuppression is present and should be reassessed regularly. The case presented in this report is being followed up regularly and the outcomes of the treatment will be assessed every three months for the next 2 years. The patient initially experienced severe pain and difficulty in eating and maintaining oral hygiene due to oral ulcers. Following treatment, there was significant reduction in pain and healing of lesions, leading to improved comfort and quality of life. The patient was satisfied with the treatment and regular follow-up care. If left untreated, PV can be fatal, with a high mortality rate due to complications such as skin involvement, electrolyte imbalance, and secondary infections. Early detection and treatment are crucial to managing the disease and preventing serious outcomes.The limitation is its a single-case report and has limited generalizability, and the absence of long-term follow-up precludes assessment of sustained outcomes and relapse. Conclusion PV has a higher propensity to impact the oral mucosa and might cause death if treatment is not received. Early recognition of atypical aerodigestive involvement in pemphigus vulgaris is crucial to prevent diagnostic delay and complications. A multidisciplinary approach, prompt immunopathological confirmation, and timely initiation of systemic therapy are essential for optimal outcomes. This will improve the quality of life of patients with early disease, and will minimize flare-ups, hospitalization, and morbidity associated with therapeutic agents to accelerate remission. This case highlights the importance of early diagnosis of pemphigus vulgaris presenting with oral manifestations. Clinical examination along with cytological and immunofluorescence investigations is essential for accurate diagnosis, and prompt corticosteroid therapy with gradual tapering can achieve successful disease control. In resource-limited settings, reliance on clinical and histopathological correlation remains important where advanced investigations are not readily available. Supplementary Information Supplementary Material 1. Supplementary Material 1.